24.4(top 1%)
Impact Factor
25.8(top 1%)
extended IF
204(top 1%)
H-Index
4.1K
authors
1.8K
papers
147.5K
citations
4.1K
citing journals
87.4K
citing authors

Most Cited Articles of Cancer Discovery

TitleYearCitations
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data20128.6K
The emergence of lncRNAs in cancer biology20111.4K
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy20181.3K
AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer20141.2K
Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy20111.2K
Patient-derived xenograft models: an emerging platform for translational cancer research20141K
The vigorous immune microenvironment of microsatellite instable colon cancer is balanced by multiple counter-inhibitory checkpoints2015890
Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy2016841
Clinical Applications of Circulating Tumor Cells and Circulating Tumor DNA as Liquid Biopsy2016840
Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors2013831
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak2020830
The basic principles of chimeric antigen receptor design2013811
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy2015713
Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy2014700
Primary Resistance to PD-1 Blockade Mediated by JAK1/2 Mutations2017692
A molecularly annotated platform of patient-derived xenografts ("xenopatients") identifies HER2 as an effective therapeutic target in cetuximab-resistant colorectal cancer2011668
EGFR-mediated re-activation of MAPK signaling contributes to insensitivity of BRAF mutant colorectal cancers to RAF inhibition with vemurafenib2012663
The BATTLE trial: personalizing therapy for lung cancer2011660
Endothelial Activation and Blood-Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells2017649
Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer2016648
Mutations and PD-1 Inhibitor Resistance in -Mutant Lung Adenocarcinoma2018648
AACR Project GENIE: Powering Precision Medicine through an International Consortium2017629
MYC, Metabolism, and Cancer2015627
The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma2014626
Cancer cell metabolism: one hallmark, many faces2012609